pubmed-article:6444530 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:6444530 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
pubmed-article:6444530 | lifeskim:mentions | umls-concept:C0439064 | lld:lifeskim |
pubmed-article:6444530 | lifeskim:mentions | umls-concept:C1709160 | lld:lifeskim |
pubmed-article:6444530 | lifeskim:mentions | umls-concept:C0002131 | lld:lifeskim |
pubmed-article:6444530 | lifeskim:mentions | umls-concept:C2003874 | lld:lifeskim |
pubmed-article:6444530 | pubmed:issue | 3 | lld:pubmed |
pubmed-article:6444530 | pubmed:dateCreated | 1980-5-14 | lld:pubmed |
pubmed-article:6444530 | pubmed:abstractText | Monoclonally-derived neoplastic T-cells from a patient with cutaneous T-cell lymphoma respond to multiple human HLA-D antigens in mixed lymphocyte culture. The implications of this phenomenon relevant to normal T-cell function and to malignancy are discussed. | lld:pubmed |
pubmed-article:6444530 | pubmed:language | eng | lld:pubmed |
pubmed-article:6444530 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:6444530 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:6444530 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:6444530 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:6444530 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:6444530 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:6444530 | pubmed:month | Mar | lld:pubmed |
pubmed-article:6444530 | pubmed:issn | 0006-4971 | lld:pubmed |
pubmed-article:6444530 | pubmed:author | pubmed-author:WarburtonDD | lld:pubmed |
pubmed-article:6444530 | pubmed:author | pubmed-author:EdelsonR LRL | lld:pubmed |
pubmed-article:6444530 | pubmed:author | pubmed-author:BergerC LCL | lld:pubmed |
pubmed-article:6444530 | pubmed:author | pubmed-author:RubenfeldM... | lld:pubmed |
pubmed-article:6444530 | pubmed:author | pubmed-author:LöfströmL MLM | lld:pubmed |
pubmed-article:6444530 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:6444530 | pubmed:volume | 55 | lld:pubmed |
pubmed-article:6444530 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:6444530 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:6444530 | pubmed:pagination | 470-3 | lld:pubmed |
pubmed-article:6444530 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:6444530 | pubmed:meshHeading | pubmed-meshheading:6444530-... | lld:pubmed |
pubmed-article:6444530 | pubmed:meshHeading | pubmed-meshheading:6444530-... | lld:pubmed |
pubmed-article:6444530 | pubmed:meshHeading | pubmed-meshheading:6444530-... | lld:pubmed |
pubmed-article:6444530 | pubmed:meshHeading | pubmed-meshheading:6444530-... | lld:pubmed |
pubmed-article:6444530 | pubmed:meshHeading | pubmed-meshheading:6444530-... | lld:pubmed |
pubmed-article:6444530 | pubmed:meshHeading | pubmed-meshheading:6444530-... | lld:pubmed |
pubmed-article:6444530 | pubmed:meshHeading | pubmed-meshheading:6444530-... | lld:pubmed |
pubmed-article:6444530 | pubmed:meshHeading | pubmed-meshheading:6444530-... | lld:pubmed |
pubmed-article:6444530 | pubmed:meshHeading | pubmed-meshheading:6444530-... | lld:pubmed |
pubmed-article:6444530 | pubmed:meshHeading | pubmed-meshheading:6444530-... | lld:pubmed |
pubmed-article:6444530 | pubmed:meshHeading | pubmed-meshheading:6444530-... | lld:pubmed |
pubmed-article:6444530 | pubmed:year | 1980 | lld:pubmed |
pubmed-article:6444530 | pubmed:articleTitle | Neoplastic human T-cells capable of responding to multiple human alloantigens. | lld:pubmed |
pubmed-article:6444530 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:6444530 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6444530 | lld:pubmed |